Phage antibodies obtained by competitive selection on complement- resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular- weight outer membrane protein

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 83-88

  Boel, Edwin ^a   Bootsma, Hester ^a   De Kruif, John ^b   Jansze, Margriet ^a   Kungman, Karin L ^c   Van Dijk, Hans ^a   Logtenberg, Ton ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; COMPLEMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; OUTER MEMBRANE PROTEIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATION; CONTROLLED STUDY; MOLECULAR WEIGHT; MORAXELLA CATARRHALIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 0031965024     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.83-88.1998     Document Type: Article

References (40)

1. Bartos, L. C., and T. F. Murphy. 1988. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J. Infect. Dis. 158:761-765.
2. Boyle, F. M., P. R. Georgiou, M. H. Tilse, and J. G. McCormack. 1991. Branhamella (Momxella) catarrhalis: pathogenic significance in respiratory infections. Mcd. J. Aust. 154:592-596.
3. Bradbury, A., L. Persic, T. Werge, and A. Cattaneo. 1993. Use of living columns to select specific phage antibodies. Bio/Technology 11:1565-1569.
4. Brandtzaeg, P., T. E. Mollnes, and P. Kierult. 1989. Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160:58-65.
5. Burton, D. R., and C. F. Barbas. 1994. Human antibodies from combinatorial libraries. Adv. Immunol. 57:191-280.
6. Cai, X., and A. Garen. 1995. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc. Natl. Acad. Sci. USA 92:6537-6541.
7. Catlin, B. W. 1990. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:293-330.
8. de Kruif, J., E. Boel, and T. Logtenherg. 1995. Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J. Mol. Biol. 248:97-105.
9. de Kruif, J., L. Terstappen, E. Boel, and T. Logtenberg. 1995. Rapid selection of cell subpopulation-spccific human monoclonal antibodies from a synthetic phage antibody library. Proc. Natl. Acad. Sci. USA 92:3938-3942.
10. de Rruif, J., A. van der Vuurst de Vries, L. Cilenti, E. Boel, W. van Ewijk, and T. Logtenberg. 1996. New perspectives on recombinant human antibodies. Immunol. Today 17:453-455.
11. Georgiou, G., H. L. Poelschke, C. Stathopoulos, and J. A. Francisco. 1993. Practical applications of engineering Gram-negative bacterial cell surfaces. Trends Biotechnol. 11:6-10.
12. Hager, H., A. Verghese, S. Alvarez, and S. L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149.
13. Helminen, M. E., K. Beach, I. Macher, G. Jarosik, E. J. Hansen, and M. Leinonen. 1995. Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Clin. Diagn. Lab. Immunol. 2:35-39.
14. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. Paris, G. H. McCraeken, and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872.
15. Helminen, M. E., I. Maciver, M. Paris, J. L. Latimer, S. L. Lumbley, L. D. Cope, G. H. McCraeken, and E. J. Hansen. 1993. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis afters serum resistance and survival in vivo. J. Infect. Dis. 168:1194-1201.
16. Hol, C., C. M. Verduin, E. E. M. van Dijke, J. Verhoef, A. Fleer, and H. van Dijk. 1995. Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis. FEMS Immunol. Med. Microhiol. 11:207-212.
17. Hol, C., C. M. Verduin, E. E. M. van Dijke, J. Verhoef, and H. van Dijk. 1993 Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet 341:1281.
18. H gene segments rearranged in vitro. J. Mol. Biol. 227:381-388.
19. Joiner, K. A., K. A. Warren, C. Hammer, and M. M. Frank. 1985. Bactericidal but not nonbactericidal C5b-C9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. J. Immunol. 134:1920-1925.
20. Rabat, E. A., T. T. Wu, H. M. Oerry, K. S. Gottesman, and C. Foeller. 1991. Sequences of proteins of immunological interest. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, Md.
21. Klingman, K. L., and T. F. Murphy. 1992. Identification and purification of the lipooligosaccharide-associated high-molecular-weight outer membrane protein (HMW-OMP) of Branhamella catarrhalis, abstr. B-388, p. 90. In Proceedings of the 1992 General Meeting of the American Society for Microbiology 1992. American Society for Microbiology, Washington, D.C.
22. Klingman, K. L., and T. F. Murphy. 1994. Purification and characterization of a high-moiecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1150-1155.
23. Mandrell, R. E., J. J. Kim, C. M. John, B. W. Gibson, J. V. Sugai, M. A. Apicella, J. M. Griffiss, and R, Yamasaki. 1991. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173:2823-2832.
24. Marks, J. D., H. R. Hoogenboom, T. P. Bonnert, J. McCafferty, A. D. Griffiths, and G. Winter. 1991. By-passing immunization. Human antibodies from V-gcne libraries displayed on phage. J. Mol. Biol. 222:581-597.
25. Marks, J. D., W. H. Ouwehand, J. M. Bye, R. Finnern, B. D. Gorick, D. Voak, S. J. Thorpe, N. C. Hughes-Jones, and G. Winter. 1993. Human antibody fragments specific for human blood group antigens from a phage display library. Bio/Technology 11:1145-1149.
26. Meulemans, E. V., R. Slobbe, P. Wasterval, F. C. S. Ramaekers, and G. J. J. M. Van Eys. 1994. Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody. J. Mol. Biol. 244:353-360.
27. Murphy, T. F. 1989. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr. Infect. Dis. J. 8:S75-S77.
28. 27a.Murphy, T. F. Personal communication.
29. Murphy, T. F., and S. Sethi. 1942. Bacterial infections in chronic obstructive pulmonary- disease. Am. Rev. Respir. Dis. 146:10b7-1083.
30. Plückthun, A., and A. Skerra. 1989. Expression of functional antibody Fv and Fab fragments in Escherichia coli. Methods Hnzymol. 178:497-515.
31. Portolano, S., S. M. McLachfan, and B. Rapoport. 1993. High affinity, thyroid-specific human auloantibodies displayed tin the surface of filamentous phage use V genes similar to other autoantibodies. J. Immunol. 151:2839-2851.
32. Sanger, F., S. Nieklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
33. H segments with different hypervariable loops. J. Mol. Biol. 227:776-798.
34. Tschopp, J., D. Masson, S. Schäfer, M. Peitsch, and K. T. Preissner. 1988. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8 and C9 and perform from cytolytic T-cells and inhibits their lytic activities. Biochemistry 27:41033-41039.
35. Verduin, C. M. 1996. Complement resistance as a virulence factor of Moraxella (Branhamella) catarrhalis. Ph.D. thesis. University of Utrecht, Utrecht, The Netherlands.
36. Verduin, C. M., H. J. Bootsma, C. Hol, A. Fleer, M. Jansze, K. L. Klingman, T. F. Murphy, and H. van Dijk. 1995. Resistance of Moraxella (Branhamella) catarrhalis to killing by human serum is mediated by high-molecular-weight outer membrane protein (HMW-OMP) and vitronectin. abstr. B-137, p. 64. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
37. Verduin, C. M., C. Hol, M. Jansze, E. E. M. van Dijke, and H. van Dijk. 1995. Complement resistance in Moraxella (Branhamella) catarrhalis is species-restricted and mediated by the binding of human vitronectin. p. 25-40. In C. M. Verduin, D. A. Watson, H. van Dijk, and J. Verhoef (ed.), Constitutional resistance to infection. R. G. Landes Company (Medical Intelligence Unit), Austin, Tex.
38. Verduin, C. M., C. Hoi, E. E. M. van Dijke, J. A. J. Faber, M. Jansze, J. Verhoef, and H. van Dijk. 1995. Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method. Clin. Diagn. Lab. Immunol. 2:365-368.
39. Verduin, C. M., M. Jansze, C. Hol, T. E. Mollnes, J. Verhoef, and H. van Dijk, 1994. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect. Immun. 62:589-595.
40. Winter, G., A. D. Griffiths, R. E. Hawkins, and H. R. Hoogenboom. 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12: 433-455.